Editas Medicine, Inc.
EDIT
DELAYED 1 MONTH
10 insider filings · Latest: Jul 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Jul 29 8:51 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Sale | 4,928 | $2.67 | $13.2K | 62,369(D) | View → |
| Jun 3, 2026 | Jun 5 8:33 PM | Amy ParisonSVP, Chief Financial Officer | Sale | 464 | $2.70 | $1.3K | 14,970(D) | View → |
| Jun 3, 2026 | Jun 5 8:33 PM | Gilmore Neil O'NeillDirector, CEO | Sale | 15,380 | $2.70 | $41.5K | 248,313(D) | View → |
| Jun 3, 2026 | Jun 5 8:32 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Sale | 731 | $2.70 | $2.0K | 67,297(D) | View → |
| Mar 3, 2026 | Mar 4 9:56 PM | Gilmore Neil O'NeillDirector, CEO | Sale | 5,394 | $2.02 | $10.9K | 263,693(D) | View → |
| Mar 3, 2026 | Mar 4 9:49 PM | Amy ParisonSVP, Chief Financial Officer | Sale | 474 | $2.02 | $957 | 15,434(D) | View → |
| Mar 3, 2026 | Mar 4 9:48 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Sale | 749 | $2.02 | $1.5K | 68,028(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 16 8:37 PM | Gilmore Neil O'NeillDirector, CEO | Grant/Award | 1,015,200 | $2.54 | 1,015,200(D) | View → |
| Mar 12, 2026 | Mar 16 8:35 PM | Amy ParisonSVP, Chief Financial Officer | Grant/Award | 292,856 | $2.54 | 292,856(D) | View → |
| Mar 12, 2026 | Mar 16 8:34 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Grant/Award | 292,856 | $2.54 | 292,856(D) | View → |